Objective-Recent studies have shown that altered mitochondrial dynamics impairs the function in senescent endothelial cells (ECs). However, the underlying molecular mechanism remains to be elucidated. Herein, we investigated the role and underlying mechanism of mitochondrial fission protein dynamin-related protein 1 (DRP1) in vascular aging. Approach and Results-We found that DRP1 expression is decreased in senescent ECs, accompanied with long interconnected mitochondria and impaired angiogenic function. In addition, there was marked increase of autophagosomes but not of autolysosomes (assessed as punctate dual fluorescent mCherry-GFP (green fluorescent protein) tandem-tagged light chain 3 expression) in senescent ECs, indicating impaired autophagic flux. DRP1 knockdown or pharmacological inhibition in young ECs resulted in elongated mitochondria, suppressed autophagic flux, premature senescence, and impaired angiogenic function. In contrast, adenoviral-mediated overexpression of DRP1 in senescent ECs restored autophagic flux and improved angiogenic function. EC senescence was associated with the increase of mitochondrial reactive oxygen species and antioxidant N-acetyl-cysteine restored autophagosome clearance and improved angiogenic function. Consistently, en face staining of old rat thoracic aorta revealed a decrease of DRP1 expression and increase of autophagosomes accumulation. Furthermore, in vivo knockdown of Drp1 in common carotid arteries significantly impaired the autophagosome clearance. Importantly, downregulation of Drp1 directly abrogated microvessels outgrowth from ex vivo aortic rings. Conclusions-These results suggest that loss of DRP1 during senescence exacerbates ECs dysfunction by increasing mitochondrial reactive oxygen species and subsequently inhibiting autophagic flux. (Arterioscler Thromb Vasc Biol.
A ging is a major risk factor for the development of cardiovascular disease. 1, 2 One of the characteristics of aging tissues is the impaired ability to regenerate, caused by the accumulation of senescent cells. 3 Vascular endothelial cells (ECs) are situated at the interface between the blood and the vascular wall and critically involved in the maintenance of vascular homeostasis in health. 4, 5 Vascular EC with senescence militates against the integrity of the endothelium and impairs angiogenesis, 6 which has been increasingly linked to the process of vascular aging and the development of cardiovascular pathologies. 7 Thus, elucidating the mechanism underlying EC senescence may provide novel therapeutic strategies for vascular diseases.
Mitochondria are highly dynamic organelles whose morphology, distribution, and activity can be regulated by fusion and fission. 8 Mitochondrial dynamics are regulated by the fusion proteins, mitofusin 1 and 2 and optic atrophy 1 (OPA1), and the fission proteins, dynamin-related protein (DRP) 1 and fission 1. 9, 10 The imbalance between mitochondrial fission and fusion affects cellular physiology and pathology. Mutations of Opa1 cause autosomal dominant OPA, whereas mutations of Drp1 lead to severe abnormal brain development. 11, 12 Interestingly, abnormally rounded mitochondria were found in many senescent postmitotic cell types and aged organisms, 13, 14 and maintenance of elongated mitochondria induces premature senescence. [12] [13] [14] [15] In addition, altered mitochondrial dynamics may impair EC function by increasing the mitochondrial reactive oxygen species (ROS) level in diabetes mellitus. 16, 17 Despite these insights, how mitochondria dynamics impact impaired EC function during senescence is not yet clear.
Dysfunctional mitochondria are selectively removed by autophagy, where the damaged organelle is engulfed by autophagosome and subsequently delivered to the lysosome for degradation. 18 Reduced autophagy results in accumulation of dysfunctional mitochondria and has been linked to aging. 19, 20 Recent studies indicate that autophagy activation may contribute to longevity and inhibition of autophagic proteins significantly shortens life span in Caenorhabditis elegans. 21 More recently, it is implicated that mitochondrial dynamic proteins are involved in the initiation of autophagy in Parkinson disease and the formation of autophagosomes in cardiomyocytes. [22] [23] [24] Nevertheless, little is known about the role of mitochondrial dynamics in regulation of autophagic process during cellular senescence.
In the present study, we sought to address whether endothelial dysfunction during senescence is determined by abnormal mitochondrial dynamics and autophagic process impairment. We investigated the significance of DRP1-mediated mitochondrial elongation in vascular aging and explored that autophagic flux may be a downstream target of DRP1. Our data showed that DRP1 deficiency during senescence inhibited the autophgic flux and eventually led to endothelial dysfunction.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Impaired Endothelial Function in Senescent Human Umbilical Cord Vein ECs
To achieve replicative senescence, freshly isolated human umbilical cord vein ECs (HUVECs) were serially passaged. We termed HUVECs in population-doubling levels <10 as young cells and HUVECs in population-doubling levels >40 as senescent cells. As shown in Figure 1A , senescent HUVECs demonstrated distinctive cellular morphological changes, including increased cell size and cytoplasmic granularity. Senescent HUVECs substantially increased the expression of senescence-associated-β-galactosidase (blue color; Figure 1A ), a reliable biochemical marker for cellular senescence activity. Compared with young HUVECs, senescent HUVECs also dramatically upregulated the expressions of p16 Ink4a and p21 Waf1/Cip1 ( Figure 1B ), cyclin-dependent kinase inhibitors known to accumulate in aging cells and be responsible for cell cycle arrest. 25, 26 To further verify HUVECs as a model for replicative senescence, we measured the senescence-associated secretory phenotype of HUVECs by ELISA. Senescent HUVECs displayed higher levels of interleukin-6, plasminogen activator inhibitor 1, and monocyte chemotactic protein 1 secretion ( Figure 1C ). The ECs identity was confirmed by high expression of CD31 in both young and senescent HUVECs ( Figure IA in the online-only Data Supplement).
To investigate the impact of cellular senescence on endothelial functions, we examined the in vitro angiogenic capacities of young and senescent HUVECs. As shown in Figure 1D , senescent HUVECs formed less developed tubule networks on matrigel, with significant reduction in both the number of tubule and the branch points. In addition, cell migration measured by transwell assay was also significantly attenuated in senescent HUVECs compared with young control HUVECs ( Figure 1E ). We then examined endothelial nitric oxide synthase expression in young and senescent HUVECs. Senescent HUVECs showed modest reduction of phosphorylated endothelial nitric oxide synthase (at Ser 1177), with no significant change of total endothelial nitric oxide synthase expression ( Figure IB in the online-only Data Supplement).
DRP1-Induced Changes of Mitochondrial Morphology in Senescent HUVECs
To determine the role of mitochondrial elongation in senescence, mitochondrial morphology was analyzed with MitoTracker Mitochondrion Selective Probes. We confirmed that senescent HUVECs exhibited extensively elongated, thread-like mitochondria, whereas young HUVECs displayed smaller punctate mitochondria ( Figure 2A ). The maintenance of mitochondrial morphology and function depend on a balance between fusion and fission machineries. 10 Next, the mRNA expression levels of fusion and fission genes (Opa1, Mfn1, Mfn2, Drp1, and Fis1) were analyzed by quantitative real-time polymerase chain reaction in young and senescent HUVECs. The transcript level of Drp1 strongly decreased in senescent HUVECs (≈54.9%), whereas the transcripts levels of Mfn1, Mfn2, Opa1, and Fis1 were not significantly altered ( Figure 2B ). Western blot analysis of DRP1, mitofusin 1, mitofusin 2, OPA1, and fission 1 also confirmed the reduction of DRP1 protein in senescent HUVECs ( Figure 2C ). Because the activity of DRP1 is important for mitochondrial fission and its activity is determined by its phosphorylation at Ser 616, we then examined the phosphorylation level of DRP1 at Ser616. We did not observe the significant change of DRP1 phosphorylation between young and senescent cells ( Figure 2C ). These results together suggest that the elongation of mitochondria in aged HUVECs was mediated by decreasing DRP1 expression.
Silencing of Drp1 Induces Senescence-Associated Phenotypic Changes and ECs Dysfunction
To ascertain the role of decreased DRP1 expression and elongation of mitochondria in EC senescence, we first silenced this gene in young HUVECs, using adenoviruses expressing short hairpin RNA of Drp1 (shRNA-Drp1). Reduction of DRP1 protein levels in silenced cells was confirmed by Western blot ( Figure IIB in the online-only Data Supplement). To control for off-target effects of shRNA, we re-expressed the Drp1 gene by adenoviral infection in the Drp1-shRNA-expressing cells. Re-expression of Drp1 rescued the depletion of DRP1 protein level and cell functional changes (FigureIII in the online-only Data Supplement), confirming that the effect of Drp1 shRNA was specific. Quantitative polymerase chain reaction analysis confirmed that this treatment did not affect other mitochondrial dynamic-related genes (data not shown). Most cells treated with the Ad-NC (adenovirus-encoding nontemplate shRNA) showed a normal short tubular mitochondrial structure, whereas the Ad-shRNA-Drp1-treated cells had an elongated, net-like structure of mitochondria ( Figure  IVC in the online-only Data Supplement). After knockdown of Drp1 gene on the cell level, young HUVECs underwent premature senescence with increasing senescence-associatedβ-galactosidase staining ( Figure 3A ), as well as p21 and p16 expression ( Figure 3B ; Figure IVB in the online-only Data Supplement), accompanied by the increase of interleukin-6, plasminogen activator inhibitor 1, and monocyte chemotactic protein 1 secretion ( Figure 3C ). We further assessed the effects of Drp1 downregulation on the ECs functions. We found that the ability of the cells to form tubule networks on matrigel and cell migration was largely attenuated in HUVECs with Drp1 knockdown ( Figure 3D and 3E).
To further confirm the role of loss-of-DRP1 function in EC senescence, we treated young HUVECs with mdivi-1 (30 μmol/L; 24 hours), a specific inhibitor of DRP1. Mdivi-1 treatment resulted in significant elongation of the mitochondrial network in ECs and increased mitochondrial connectivity ( Figure including impaired EC tube formation and cell migration ( Figure 3D and 3E ). Furthermore, CCK-8 assay shows that there is no significant toxicity observed after Ad-shRNA-Drp1 and mdivi-1 treatment ( Figure IVA in the online-only Data Supplement). Taken together, these results indicate that prolonged depletion of Drp1 can induce premature senescence and loss of angiogenic capacities.
Impairment of Autophagic Degradation Causes Endothelial Senescence and Dysfunction
Turnover assays of autophagy-related proteins such as microtubule-associated protein light chain 3 (LC3) and p62 are used as indicator of autophagic flux. 27 To address the role of autophagic process in cellular senescence, chloroquine (5 μmol/L; 24 hours), the lysosome acidification inhibitor, was introduced into young and senescent HUVECs to interrupt the degradation of autophagosomes. Cell viability assay revealed no cytotoxicity by chloroquine treatment ( Figure VA in the online-only Data Supplement). Inhibition of lysosomes led to a significant accumulation of autophagosomes in young HUVECs, as indicated by the increased level of microtubuleassociated protein light chain 3B (LC3-II) and p62 in the presence of chloroquine, suggesting intact autophagic flux ( Figure 4A ). However, there is no significant change in the level of LC3-II and p62 in senescent HUVECs, indicating that there is already-impairment of autophagosomes processing in senescent HUVECs ( Figure 4A ).
To further support the observation of impaired autophagosome processing with endothelial senescence, the relative abundance of autophagosomes and autolysosomes was assessed with adenovirally transduced mCherry-green fluorescent protein (GFP) tandem-tagged LC3 as described previously. 28, 29 In the acidic environment of autolysosomes, red fluorescence of mCherry retains its fluorescence, whereas GFP loses its fluorescence. As a result, autophagosomes possess both red and green fluorescence, generating yellow puncta, whereas autolysosomes have only red fluorescence. Young HUVECs demonstrated constitutive (basal) autophagy with a preponderance of autolysosomes (red only dots) and a few autophagosomes (yellow dots; Figure 4B ). In contrast, senescent HUVECs exhibited accumulation of autophagosomes and marked reduction of autolysosomes ( Figure 4B ). Taken together, these results indicate that autophagic degradation was defective in senescent HUVECs.
To determine whether impairment of autophagosome processing is responsible for HUVECs senescence and dysfunction, we pretreated young HUVECs with chloroquine. The effect of chloroquine on in vitro angiogenesis was then examined using matrigel assay and transwell assay. Results showed that young HUVECs treated with chloroquine formed much more incomplete and poorly connected tube networks than those of untreated HUVECs ( Figure 4C) . Consistently, the number of migration cells was significantly decreased after chloroquine treatment ( Figure 4D ). Moreover, we found significantly enhanced senescence-associated-β-galactosidasepositive cells and protein level of p21 and p16 after the chloroquine treatment ( Figure VB and VC in the online-only Data Supplement). Induction of senescence was also verified by increased expression of other senescence marker interleukin-6, plasminogen activator inhibitor 1, and monocyte 
Role of DRP1 in the Regulation of Autophagic Activity
The question raised here is whether the accumulation of autophagosomes is mainly because of the mitochondrial elongation by decline of DRP1 in senescent HUVECs. To address this question, we first assessed the inhibition of DRP1 by pharmacological (mdivi-1) or genetic (shRNA-mediated knockdown) approach in young HUVECs. We found that inhibition of DRP1 resulted in accumulation of the autophagosomes without an increase in autolysosomes ( Figure 5A ). Inhibition of DRP1 also provoked an increase in the protein level of LC3-II and p62 in young HUVECs, and however, there is no further increase in the levels of LC3-II and p62 after additional treatment of chloroquine ( Figure 5B ; Figure VIA and VIB in the online-only Data Supplement), suggesting the impaired autophagosome clearance. Next, we overexpressed Drp1 in senescent HUVECs, using adenovirus-encoding human Drp1. Overexpression efficiency of Drp1 in HUVECs was confirmed by Western blot ( Figure IIB in the online-only Data Supplement). Senescent HUVECs overexpression Drp1 showed fragmented mitochondrial morphology ( Figure IVC in the online-only Data Supplement). We found that overexpressing Drp1 in senescent HUVECs decreased the protein levels of LC3-II and p62 and increased the autolysosome number ( Figure 5A ), but in the presence of chloroquine, the LC3-II and p62 levels were significantly increased ( Figure 5B ; Figure VIA and VIB in the online-only Data Supplement), indicating the restoration of autophagic flux. These data suggest that the DRP1-induced mitochondrial elongation during endothelial senescence provokes autophagosome formation but impairs their clearance.
DRP1 Regulates Autophagic Flux and Endothelial Function Through Modulating ROS Level
We sought to identify the signals involved in the effect of mitochondrial elongation followed by Drp1 downregulation on the autophagic process in senescent ECs. Cellular senescence can be induced by sublethal stresses, such as accumulation of ROS and DNA damage. 30, 31 Furthermore, the accumulation of mitochondrial damage is one of the most widely accepted causes of aging. 32, 33 Therefore, we examined the mitochondrial ROS levels with MitoSOX Red Mitochondrial Superoxide Indicator and found that excessive mitochondrial superoxide was accumulated in senescent HUVECs ( Figure 6A) . Treatment with N-acetyl-cysteine (NAC; 200 μmol/L; 24 hours), a glutathione precursor that acts as an ROS scavenger reduced the mitochondrial superoxide ( Figure 6A ). No significant toxicity was observed after NAC treatment compared with the control group ( Figure VIIA of p21, p16, and senescence-associated secretory phenotypes in senescent HUVECs ( Figure VIIC and VIID in the online-only Data Supplement), suggesting an important role for mitochondrial oxidative stress in the impaired endothelial functions associated with aging. More importantly, we found that overexpressing Drp1 via Ad-Drp1 strikingly reduced the mitochondrial superoxide and increased the autolysosome number in senescent HUVECs. Depletion or inhibition of DRP1 increased ROS level and impaired the autophagic process in young HUVECs (Figures 5 and 6A ; Figure VI in the online-only Data Supplement ). To determine whether the Drp1 regulation of autophagic flux was through modulating cellular ROS level, we examined autophagic flux and endothelial function after Drp1 overexpression in the presence of NAC treatment in senescent HUVECs. We observed that Drp1 overexpression and NAC treatment combined had no significant additive effect ( Figure 6B-6D ; Figure VIIB -VIID in the online-only Data Supplement) compared with only NAC treatment or Drp1 overexpression, indicating that DRP1 regulates the autophagic flux mainly through modulating the ROS level. Taken together, these data suggest that DRP1 downregulation in aging ECs suppresses autophagic process and subsequently contributes to the senescence-associated phenotypic change, which is predominantly through increasing mitochondrial ROS level.
Decreased DRP1 Expression and Impaired Autophagic Flux in Aged Rats
To determine whether there are senescent vascular ECs in old rat, we examined senescence-associated-β-galactosidase activity in the thoracic aortas obtained from normal young (2 months) and old (22 months) Wistar-Kyoto rats. Strong β-galactosidase staining was observed throughout the surface of aorta endothelium from old rat, whereas aorta from young rat showed a little staining ( Figure 7A ). To elucidate whether DRP1 is involved in vascular aging in vivo, en face immunofluorescence staining of endothelial DRP1, mitofusin 1, mitofusin 2, OPA1, and fission 1 on rat aorta was performed. We found that only DRP1 was dramatically decreased in the aortic ECs of old rat compared with young rat ( Figure 7B ; Figure  VIIIA links ubiquitinated aggregates for destruction within autophagosomes and is degraded on autophagosome processing, also increased in the aortic ECs of old rat ( Figure 7B ; Figure VIIIA in the online-only Data Supplement), suggesting impaired autophagic processing.
To further study the effect of DRP1 on angiogenesis in an ex vivo condition, the migration and proliferation of rat aortic ECs were examined using the aortic ring assay. Aortic rings were infected with Ad-NC or Ad-shRNA-Drp1 and cultured for 9 days in MCDB131 medium. Vasculogenesis was observed after 9 days of culture. Figure 7C shows microvessels outgrowth from the untreated or Ad-NCinfected aortic rings. On the contrary, aortic rings infected with Ad-shRNA-Drp1 significantly reduced outgrowth of capillary sprouts.
To determine whether DRP1 regulates the autophagy in vivo, rat carotid arteries were infected with Ad-NC or Ad-shRNA-Drp1 in vivo. Reduction of DRP1 protein levels in carotid arteries was confirmed by Western blot 72 hours after Ad-shRNA-Drp1 infection ( Figure VIIIC in the online-only Data Supplement). En face staining of common carotid arteries indicated that Drp1 knockdown markedly enhanced the number of LC3 puncta and the expression level of p62 ( Figure 7D ; Figure VIIID in the online-only Data Supplement), suggesting that decreased Drp1 led to impaired endothelial function and autopahgic flux in vivo. These results suggest a possible role for DRP1 in the regulation of autophagic flux and angiogenesis in vascular aging.
Discussion
In this study, we demonstrated that loss of DRP1 during senescence impairs the endothelial function through suppressing the autophagic flux via upregulating mitochondrial ROS level. Several lines of evidence are provided to support our hypothesis. First, DRP1 expression is significantly decreased in senescent ECs, which is paralleled by a decreased activity of autophagy. Second, knockdown of Drp1 or inhibition of autophagic flux leads to the onset of senescence and endothelial dysfunction. Third, DRP1 regulates the autophagic flux by modulating the mitochondrial ROS level.
Mitochondrial fission is critical for the maintenance of mitochondrial function, and alterations of this process have been linked to many human diseases. In mammalian cells, DRP1 and fission 1 regulate mitochondrial fission, and deficiency of Drp1 or Fis1 leads to elongation of mitochondrial tubules, whereas overexpression of either restores mitochondrial morphology. 34 A recent study reports that depletion of the Drp1 gene delays the transformation of filamentous to punctuate mitochondria and retards aging in fungal. 35 In contrast, loss of mitochondrial division increases oxidative damage in mitochondria and causes cell death in mammalian neurons. 36, 37 The appearance of abnormally rounded mitochondria has long been recognized to increase during aging in mammals. 38 Consistent with this notion, we found similar elongated and interconnected mitochondria in senescent HUVECs, which were caused by downregulation of DRP1 expression ( Figure 2 ). Using pharmacological inhibition or gene silencing, we demonstrated that loss of DRP1 was sufficient to endothelial replicative senescence. Senescence of ECs limiting the ability for angiogenesis and vascular healing has emerged as a contributor to endothelial dysfunction developing. 39 Importantly, this study shows that inhibition of DRP1 induces EC senescence and promotes endothelial dysfunction (Figure 3 ). Taken together, these data indicate that DRP1 is involved in the endothelial dysfunction during senescence.
Autophagy is an intracellular bulk degradation system important for cell homeostasis, yet how mitochondrial dynamics regulate autophagy in vascular ECs is still an open question. This study provides evidence that DRP1 in HUVECs is profoundly involved in the regulation of autophagy. It should also be noted that in a recent publication Ikeda et al 40 discussed their work on DRP1 in mitochondrial autophagy and cardiac protection of ischemia/reperfusion injury. Thus, our finding in senescent ECs and the finding of Ikeda et al 40 in cardiac cells together further confirm the importance of DRP1 in regulating autophagy and also suggest that this might be a common mechanism in advanced aging and cardiovascular diseases. We used complementary approaches permitting increased accuracy in the assessment of autophagic flux. 41 We used an LC3 construct tandem-tagged with mCherry and GFP probes, which have comparable intensities and photostability in the assessment of autophagic flux. In the present study, we found that inhibition of DRP1 suppressed the autophagosome and lysosome fusion with accumulation of autphagosome number. Moreover, restoration of autophagic degradation by the overexpression of Drp1 in senescent ECs further confirmed the critical role of DRP1 in regulating the autophagic process ( Figure 5 ). Then, inhibiting autophagosome-lysosome fusion by chloroquine in young HUVECs increased the LC3-II and p62 protein to a level comparable with that of senescent HUVECs at basal levels, suggesting impaired autophagosome clearance in senescent HUVECs. Several evidences reveal that autophagy is an essential in vivo process mediating accurate EC function. 42 Pharmacological inhibition of autophagic flux or knockdown of the essential autophagy genes inhibits the maturation and secretion of endothelial von Willebrand factor. 43 Under steady laminar shear stress, autophagy upregulates the endothelial nitric oxide synthase expression and inhibits endothelin-1 expression, whereas blocking autophagy restores the endothelin-1 expression and inhibits the endothelial nitric oxide synthase expression. 44 Autophagy may directly influence the EC function by regulating endothelial cytokine expression. Similarly, our data demonstrated that impaired autophagic activity by chloroquine induced endothelial dysfunction in young HUVECs (Figure 4C and 4D) .
Oxidative stress is crucially involved in the aging process in ECs, 45 and we have reported that mitochondrial oxidative stress was significantly augmented in senescent HUVECs. It is noteworthy that ROS scavenger NAC treatment restored the autophagic flux and partly rescued the senescent pheonotype of senescent HUVECs ( Figure 6 ). Genetic manipulation of Drp1 demonstrated that the mitochondrial ROS was regulated by the Drp1 in HUVECs ( Figure 6A ). Furthermore, no significant additive effect on autophagic activity was observed by combining Drp1 overexpression and ROS inhibition ( Figure 6B-6D ), indicating that DRP1 is an upstream regulator of ROS in the regulation of autophagy. During senescence, loss of DRP1 induces endothelial dysfunction through inhibiting the autophagic process via upregulating ROS level. Impaired autophagy subsequently induces accumulation of damaged mitochondria, which in turn stimulates the produce of more ROS, leading to a perpetuating vicious cycle ( Figure  IX in the online-only Data Supplement).
Interestingly, we identified that DRP1 was decreased in aortic endothelium from old rat compared with young rat in association with accumulation of autophagosomes ( Figure 7) . Ex vivo and in vivo downregulation of DRP1 significantly increased the expression level of LC3-II and p62 and inhibited the angiogenesis of aortic rings. Although further medicine intervention experiments in vivo are needed, our results suggest that modulation of DRP1-ROS-autophagic processing signaling may represent a therapeutic approach to treat ageassociated vascular pathologies.
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